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Abstract 
This present study investigates the effect of the Vernonia amygdalina Delile (Bitter leaf) on some biochemical 
parameters such as fasting blood glucose, serum lipid profile, serum electrolytes, activities of the transaminases 
and alkaline phosphatase, in alloxan-induced diabetic rats. Twenty adult albino rats were used and grouped into 
four of five (5) rats each: control, diabetic untreated rats, diabetic rats administered with V. amygdalina (400 
mg/kg) and normal rats fed with V. amygdalina (400 mg/kg) daily respectively. All rats except those in control and 
normal rats fed with V. amygdalina (400 mg/kg) group were induced intraperitoneal with a single dose of 150 
mg/kg of alloxan. Aqueous extract of V. amygdalina leaf had hypoglycaemic effect when monitored as there was 
significant increase in the diabetic control groups (5.07 ± 0.15 mmol/L) when compared with diabetic treated 
groups. Also, the effect of the V. amygdalina extract on the activities of the transaminases and the alkaline 
phosphatase reveals a considerable increase in the diabetic control group compared to the diabetic treated 
group. From our study, the V. amygdalina leaf extract proved to have hypoglycaemic effect by significantly 
reducing the blood glucose level in diabetic treated rats as it has a great potential of serving as a supplementary 
therapy to oral hypoglycaemic drugs. 
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Introduction 
Diabetes mellitus (DM) is a metabolic 
syndrome defined by hyperglycemia caused by lack 
of insulin or disruption of insulin signalling as a 
result of lack of hypoglycemic agent or insensitivity 
of insulin hormone. DM is related to aberrant 
metabolism of macromolecules (1, 2).  The 
prevalence of this syndrome worldwide is at an 
increasing rate, which led to the uses of several 
therapeutic approaches (currently available) for the 
management of this chronic metabolic disorder, 
including the stimulation of endogenous insulin 
secretion, improvement of insulin action at the 
target sites, inhibition of dietary starch and lipid 
degradation, and treatment with oral hypoglycemic 
agents (3, 4, 5). In Africa, there has been vigorous 
growth of phyto-pharmaceuticals with proven 
efficacy in a variety of medicinal problems. Among 
other things, demand for the use of plant natural 
products with antidiabetic activity due to low cost, 
easy availability and lesser side effects has been on 
the rise. Therefore, plant constituents are 
constantly explored and examined for their effect as 
hypoglycemic agents. One of such plant is Vernonia 
amygdalina. 
Vernonia amygdalina commonly called Bitter 
leaf is a medicinal plant of the family Asteraceae. It is 
a small perennial shrub that grows in tropical Africa. 
It is found in Angola, Burundi, Cameroun, Central 
Africa Republic, Nigeria and in many other countries. 
It is widely called Ewuro in Yoruba land. The leaves 
of the plant may be consumed either as a vegetable 
(macerated leaves in soup) after rounds of washing 
to remove the bitter taste, or aqueous extract as 
tonics for the treatment of various illnesses (6).   V. 
amygdalina is rich in minerals sources such as K+, 
Ca2+, Na+, P3-, Mg2+, Mn2+, Fe2+, Cu2+ and Zn2+ (7).  It 
also contains saponins, tannins, ascorbic acid, amino 
acids (glycine, cysteine and nicotinamide), iodine, 
hydrochloric acid, sugar and oxalate (8,9). Extract of 
V. amygdalina is used traditionally to cure a number 
of ailments and its actions include, anti-
inflammatory, wound healing, immune modulation, 
anti-tumour, anti-bacteria, antiviral laxative and 
purgative properties (10, 11, 12, 13). V. amygdalina 
can also be used as food supplements when 
prepared with melon (egusi soup) a nutritious 
African food (14).  This study seeks to investigate 
the effect of aqueous extract of V. amygdalina 
leaves on alloxan-induced metabolic syndrome in 
Wistar rats. 
Methods 
Chemicals and Reagents 
 The following reagents were used; Alloxan 
monohydrate, Normal Saline, chloroform, Total 
cholesterol, High density lipoprotein (HDL)-
cholesterol, Low density lipoprotein (LDL)- 
cholesterol, very low density lipoprotein (VLDL)- 
cholesterol and triglycerides assay kits used were 
product of Randox Laboratories Ltd., Antrim, UK. All 
other chemicals were of analytical grades and 
prepared in all-glass apparatus using sterilized 
distilled water (BDH, UK).  
Sources of Plant Material and Identification 
 Fresh leaves of bitter leaf were gathered from a 
suburb of Naraguta Hostel Area, Plateau State. It 
was identified as V. amygdalina by Mr. Thomas 
Yakubu of Pharmacognosy Department, University 
of Jos, with the identification number, 
UJ/PCG/HSP/13A03. 
Preparation of V. amygdalina (Bitter Leaf) Extract 
 Fresh leaves of V. amygdalina were cut off their 
stalk and stripped their mid rib. The stripped leaves 
were thoroughly rinsed in clean water and left over 
night to be properly drained of the washed water. 
Thus prepared leaves were then pulverized to 
powder using an electric blender. Weighed samples 
were macerated in known volume of distilled water 
and left for 24 hrs (15). It was then filtered with a 
what man no1 filter paper. The filtrate was oven 
dried at 50 °C to obtain the dry paste of the extract 
which was used to prepare a stock solution of the 
extract. The weight of the dry paste extract was 
11.7g. The dried extract was then diluted with 
distilled water (10g dissolved in 100 mL), poured into 
a clean well labelled container and stored until when 
needed. 
Experimental animals  
Twenty adult albino rats were used in this study. 
They were obtained from the cage yard of Dr (Mrs.) 
Johnson of the Department of Biochemistry, 
University of Jos, Nigeria. Their weight was between 
120g and 170g. The animals were kept in large clean 
spacious cages and were given food and water ad 
libitum. The animal room was well ventilated with a 
12 h light/dark cycle, throughout the period of the 
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experiment. They were fed ad libitum on rat pellets 
(Top Feeds, Nigeria) and water. The handling of 
animals was conformed to the standards of National 
Institute of Health (NIH publication 85-23, 1985) for 
experimental animal maintenance. 
Induction of diabetes  
A single dose of 150 mg/kg of alloxan monohydrate 
was dissolved in normal saline (0.9%) and induced 
into the already fasted rats by single intraperitoneal 
injection. Forty-eight hours after the induction, the 
animals were fasted and the blood glucose level was 
checked using Accu chek Glucometer. Only the 
animals with fasting blood glucose level ≥ 200 mg/dl 
was used in this study (16). 
Animal distribution 
Twenty Adult Wistar rats were randomized into four 
groups as follows: Healthy control (received distilled 
water), diabetic untreated group, diabetic + V. 
amygdalina (400 mg/kg body weight), normal + V. 
amygdalina (400 mg/kg body weight). 
Collection of Blood samples and Glucose Evaluation 
 Blood sample from each animal was 
collected through their jugular vein and preserved 
until further processing. The blood sample was 
collected into a dry tube and allowed to clot for 30 
min before centrifuging at 3,500 rpm for 10 min to 
collect the serum (16). Collection and evaluation was 
done in all the groups before induction with Alloxan, 
after 48 hrs of induction with alloxan and after 
administration of V. amygdalina extract via oral 
gavage for fourteen (14) days of treatment. The rats 
were anaesthetized with chloroform to maintain 
calmness during blood collection and 3.5 mL of 
blood were collected from each rat for further 
biochemical examinations.  
Biochemical Parameters 
Serum lipid concentrations, in additional to 
aspartate and alanine aminotransferases and 
alkaline phosphatase as well as urea and creatinine 
concentrations, sodium (Na+), potassium (K+), 
chloride (Cl-) were measured by means of an 
Automated Chemistry Analyzer. 
Low Density Lipoprotein-cholesterol was estimated 
according to equation as shown below: 
LDL-Cholesterol (mg/dl) = TC- HDL- (TG/5) 
Whereas, TG/5 is equivalent to the concentration of 
Very Low Density Lipoprotein-cholesterol. TC: total 
cholesterol; TG means triacylglycerol (17). 
Data analysis 
All data are expressed at mean ± standard error of 
mean (SEM). The data were analyzed by one-way 
analysis of variance via a statistical software 
package (SPSS, Version 20.0, IBM Corporation, NY, 
USA) using Duncan multiple range post-hoc test 
(DMRT). Values were considered to be significantly 
different at p < 0.05.  
Results 
Table 1 shows extremely significant increase 
(p < 0.05) in the fasting blood glucose level of 
diabetes-induced groups when compared with the 
healthy control. High serum levels of cholesterol 
were obtained in diabetic control compared with 
the diabetic treated and healthy controls. Diabetic 
untreated rats show a significant increase (p < 0.05) 
in triglycerides and LDL concentrations when 
compared to the healthy control, diabetic rats 
administered with V. amygdalina and normal rats fed 
with V. amygdalina extract Table 2. Diabetic 
untreated group also shows a significant decrease 
(p < 0.05) in HDL (good cholesterol) concentrations 
when compared to healthy control, diabetic rats 
administered with V. amygdalina and normal rats fed 
with V. amygdalina extract.  
Table 3 shows the effect of the V. 
amygdalina extract on the activities of alkaline 
phosphatase, alanine aminotransferase and 
aspartate aminotransferase in normal and diabetic 
rats. There was considerably increase in the activity 
of ALP, AST and ALT in the diabetic control group 
compared to healthy control, diabetic rats 
administered with V. amygdalina and normal rats fed 
with V. amygdalina extract. 
 Table 4 shows the effect of the V. amygdalina 
extract on the activities of Billirubin (Total), 
Billirubin (Conjugated) in healthy control and 
diabetic rats. There was significant increase in the 
diabetic control groups compared to healthy 
control, diabetic rats administered with V. 
amygdalina and normal rats fed with V. amygdalina 
extract. 
 Table 5 shows the effect of the V. amygdalina 
extract on the activities of sodium, potassium, 
chloride, bicarbonate, urea and creatinine in normal 
and diabetic rats. Significant increase (P < 0.05) in 
sodium, potassium, chloride, bicarbonate, urea and 
creatinine was observed in the diabetic control 
when compared to healthy control, diabetic rats 
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administered with V. amygdalina and normal rats fed 
with V. amygdalina extract.  
Discussion 
The result confirms that V. amygdalina has 
anti-diabetic properties and these was seen in the 
experiment conducted on the various groups of 
rats. Alloxan-induced metabolic syndrome is 
characterized by hyperglycemia, polydipsia, 
polyphagia and polyuria. In the present study, 
considerably elevated fasting blood glucose levels 
was efficiently induced. Administration of aqueous 
extract of V. amygdalina leaves significantly 
decreased blood glucose levels to almost their basal 
blood sugar levels Table 1. This hypoglycaemic effect 
may be due to depression of key gluconeogenic or 
the increase in the levels of glucose transports and 
stimulation of uptake in peripheral tissues (18). 
Another possible effect of this plant extract may be 
that it preserves the cells of islets of Langerhans of 
β -cells functions, which result in a significant 
increase in insulin activity (16, 19, 20).  
Abnormal lipid metabolism, resulting in 
amassing of LDL-C and total cholesterol in addition 
to reduced HDL-cholesterol, is often related to 
diabetes mellitus (21, 22). Elevated levels of LDL, and 
total cholesterol are thought of as main menace for 
cardiovascular disease (CVD). On the contrary, 
elevated HDL-cholesterol that functions in the 
transport of cholesterol from the periphery to the 
liver reduces the chance of CVD (23). Consistent 
with this, a considerable raise on serum lipid profiles 
with a decrease on serum HDL-cholesterol in 
diabetic untreated compared with normal control. 
Oral intervention of V. amygdalina leaf aqueous 
extract averts dyslipidemia, and amplified serum 
HDL-cholesterol level. This is in accordance with 
newly published studies (21, 24). This could be due 
to the effect of Cuisine which is a component of V. 
amygdalina, which reduces low density lipoprotein 
cholesterol by 50% (25), while also boosting good 
high density lipoprotein cholesterol.  
 
Elevated serum transaminase, alanine 
aminotransferase (ALT), aspartate 
aminotransaminse (AST), alkaline phosphatase 
(ALP), urea and creatinine levels are thought of as 
biomarkers of hepato-renal damage, related to liver 
disease and hyperglycaemia (26, 27). There was 
significant increase in the three liver enzymes of 
diabetic control when compared to normal control, 
diabetic rats administered with V. amygdalina and 
normal rats fed with V. amygdalina extract. This 
indicates that the extract has the effect of 
preventing hepatocellular injury and obstructive 
liver disease in liver damaged conditions in a 
diabetic state.  
The effect of the V. amygdalina extract on the 
kidney was monitored on the electrolyte 
parameters such as sodium (Na+), potassium (K+), 
chloride (Cl-), bicarbonate (HCO3-), urea and 
creatinine as there was significant increase in the 
diabetic control compared to normal control, 
diabetic rats administered with V. amygdalina and 
normal rats fed with V. amygdalina extract. It has 
been postulated that increased levels of serum urea 
and creatinine are linked to kidney disease (26, 28, 
29).  In this study, it has been shown that V. 
amygdalina leaf extract reduces blood glucose level 
in diabetic rats, by proving its hypoglycaemic effect. 
Therefore, V. amygdalina leaf extracts has a great 
potential to be used as supplementary treatment to 
oral hypoglycaemic drugs in the management of 
diabetes mellitus in humans as well as preventing 
hepatocellular injury and obstructive liver disease in 
diabetic conditions due to the suppression of 
hepatic enzymes in diabetic state. 
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Table 1. Effects of aqueous extract V. amygdalina leaves on the fasting blood glucose level of alloxan-induced diabetic rats 
before, during and after induction of alloxan. 
Groups Initial fasting blood 
glucose level 
(mg/dl) 
Fasting blood glucose at 
72 h after induction 
(mg/dl) 
Final fasting blood 
glucose at 15 days 
after induction 
(mg/dl) 
Healthy Control 71.28 ± 0.14a 75.25 ± 0.10a 77.18 ± 1.14a 
Diabetic control 82.21  ± 1.01a 262.80 ± 1.01c 355.42 ± 3.14d 
Normal + Extract 71.14  ± 0.21a 73.20 ± 0.45a 70.20  ± 1.10a 
Diabetic + Extract 78.24  ± 1.42a 224.23 ± 1.32b 91.26 ± 0.76c 
Data are presented as the mean ± SEM of 5 rats per group. a-cValues with different letters along a row for a given parameter 
are significantly different from each other (Duncan multiple range post hoc test, p < 0.05). 
 
Table 2. Effect of V. amygdalina extract on triglycerides, total cholesterol, high density lipoprotein cholesterol (HDL) and low 
density lipoprotein cholesterol (LDL) in alloxan induced diabetic rats 
Groups TG (mmol/L) TC (mmol/L) HDL (mmol/L) LDL (mmol/L) 
Healthy Control 10.57 ± 0.35a 21.33 ± 0.21a 58.63 ± 1.06a 20.91 ± 0.06a 
Diabetic Control 54.40 ± 1.17b 71.60 ± 1.65b 21.53 ± 0.12b 85.17 ± 1.08b 
Normal + Extract 10.40 ± 0.20a 21.12 ± 0.31a 58.43 ± 1.15a 20.97 ± 0.02a 
Diabetic + Extract 25.47 ± 1.06c 42.90 ± 1.10c 38.50 ± 1.10c 41.46 ± 0.21c 
Data are presented as the mean ± SEM of 5 rats per group. a-cValues with different superscript letters along a column for a 
given parameter are significantly different from each other. TC, Total cholesterol; TG, Triglyceride; LDL-cholesterol, Low 
density lipoprotein-cholesterol; HDL-cholesterol; High density lipoprotein-cholesterol. 
 
Table 3. Effect of V. amygdalina leaf extract on alanine aminotransferase (ALT) aspartate aminotransferase (AST) and alkaline 
phosphatase (ALP) in alloxan induced diabetic rats 
Groups ALT (U/L) AST (U/L) ALP (U/L) 
Healthy Control 53.33 ± 3.89a 52.67 ± 1.02a 37.35 ± 1.35a 
Diabetic Control 139.67 ± 10.93b 143.22 ± 9.64b 78.33 ± 3.03b 
Normal + Extract 52.22 ± 3.57a 51.18 ± 2.64a 37.33 ± 1.62a 
Diabetic + Extract 89.33 ± 5.16c 78.00 ± 5.11c 55.33 ± 2.45c 
Data are presented as the mean ± SEM of 5 rats per group. a-cValues with different superscript letters along a column for a 
given parameter are significantly different from each other. ALT, Alanine transaminases; AST, Aspartate transaminases; ALP, 
Alkaline phosphatases. 
 
Table 4. Effect of V. amygdalina leaf extract on total bilirubin, conjugated bilirubin, albumin and total protein in alloxan 
induced diabetic rats 
Groups Total Bilirubin 
(µmol/L) 
Conjugated Bilirubin 
(µmol/L) 
Albumin 
(mmol/L) 
Total Protein (g/l) 
Healthy Control 6.37 ± 0.12a 5.18 ± 0.30a 56.33 ± 2.35a 39.67 ± 1.51a 
Diabetic Control 19.20 ± 1.21b 15.10 ± 1.45b 15.56 ± 1.34b 17.67 ± 1.02b 
Normal + Extract 6.20 ± 0.15a 5.12 ± 0.31a 53.67 ± 2.03a 38.00 ± 1.72a 
Diabetic + Extract 10.27 ± 0.95c 9.63 ± 1.12c 34.00 ± 1.46c 28.33 ± 1.06c 
Data are presented as the mean ± SEM of 5 rats per group. a-cValues with different superscript 
letters along a column for a given parameter are significantly different from each other. 
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Table 5. Effect of V. amygdalina leaf extract on the activities of sodium, potassium, chloride, bicarbonate, urea and creatinine 
in alloxan induced diabetic rats 
Groups Na+ (mmol/L) K+ (mmol/L) Cl- (mmol/L) HCO3- (mmol/L) Urea (mmol/L) Creatinine 
(mmol/L) 
Healthy Control 35.0 ± 1.12a 36.91±1.26a 34.33±1.08a 27.12 ± 1.65a 5.90 ± 0.52a 53.33 ± 1.09a 
Diabetic Control 87.3 ± 1.16b 86.03±3.25b 103.67±7.64b 79.33 ± 2.16b 13.87 ± 2.06b 120.67 ± 9.87b 
Normal + Extract 30.0 ± 2.34a 36.03±1.15a 34.54±1.29a 25.12 ± 1.45a 5.87 ± 0.65a 54.67 ± 1.21a 
Diabetic + Extract 63.0 ± 1.20c 66.04±1.35c 65.33±1.53c 59.67 ± 1.59c 9.43 ± 1.11c 61.67 ± 1.87c 
Data are presented as the mean ± SEM of 5 rats per group. a-cValues with different superscript letters along a column for a 
given parameter are significantly different from each other. Na+, sodium, K+, potassium, Cl-, chloride, HCO3-, bicarbonate, 
Urea, Creatinine. 
 
 
 
 
 
 
 
 
 
 
